Kiran Turaga, MD, MPH

Smilow Cancer Hospital at Yale New Haven
New Haven, CT 06511

For an introduction to this
physician call: 877-362-1554

• Lisa Hyde-Barrett

Kiran Turaga, MD, MPH, is Division Chief of Surgical Oncology in the Department of Surgery and Assistant Medical Director for the Clinical Trials Office at Yale Cancer Center. Dr. Turaga joined Yale Cancer Center and Smilow Cancer Hospital from the University of Chicago where he was Vice Chief of the Section of General Surgery and Surgical Oncology, Director of the Surgical Gastrointestinal Cancer Program, and Director of Regional Therapeutics.

Dr. Turaga is a surgical oncologist with a special interest in the treatment of advanced malignancies, including metastatic cancers (cancers that have spread beyond their original site to other parts of the body). He is an expert in regional perfusion including hyperthermic intraperitoneal chemotherapy (HIPEC), a technique that delivers high doses of heated chemotherapy directly to abdominal organs to kill cancer cells that may remain after surgical removal of visible tumors. Dr. Turaga treats a wide range of abdominal and peritoneal diseases, including colon cancer, appendix cancer, and mesothelioma and malignant bowel obstructions. He is highly skilled in minimally invasive approaches, including robotic surgery, and uses these innovative techniques to surgically treat and remove life-threatening cancers with smaller incisions and shorter recovery times.

Dr. Turaga is an avid and influential researcher who has published over 100 peer-reviewed articles and is an international authority on peritoneal surface disease. His clinical research focuses on development of novel diagnostics and therapeutics for oligo-metastatic cancer. He is also interested in studying how big data systems can be used to provide the most optimal, cost-effective patient care.